Fresenius Medical Care AG (FMS)
18.92
+0.32
(+1.72%)
USD |
NYSE |
Apr 17, 15:31
Fresenius Medical Care Cash from Operations (TTM): 2.846B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.846B |
September 30, 2023 | 2.786B |
June 30, 2023 | 2.570B |
March 31, 2023 | 2.261B |
December 31, 2022 | 2.286B |
September 30, 2022 | 2.378B |
June 30, 2022 | 2.555B |
March 31, 2022 | 2.873B |
December 31, 2021 | 2.946B |
September 30, 2021 | 2.714B |
June 30, 2021 | 2.997B |
March 31, 2021 | 4.440B |
December 31, 2020 | 4.834B |
September 30, 2020 | 5.144B |
June 30, 2020 | 5.029B |
March 31, 2020 | 3.432B |
December 31, 2019 | 2.874B |
September 30, 2019 | 2.846B |
June 30, 2019 | 2.748B |
March 31, 2019 | 2.576B |
December 31, 2018 | 2.435B |
September 30, 2018 | 2.113B |
June 30, 2018 | 2.054B |
March 31, 2018 | 2.247B |
December 31, 2017 | 2.482B |
Date | Value |
---|---|
September 30, 2017 | 2.799B |
June 30, 2017 | 2.429B |
March 31, 2017 | 2.139B |
December 31, 2016 | 2.138B |
September 30, 2016 | 1.861B |
June 30, 2016 | 2.007B |
March 31, 2016 | 1.674B |
December 31, 2015 | 1.960B |
September 30, 2015 | 2.100B |
June 30, 2015 | 2.291B |
March 31, 2015 | 2.390B |
December 31, 2014 | 2.036B |
September 30, 2014 | 1.867B |
June 30, 2014 | 1.678B |
March 31, 2014 | 1.744B |
December 31, 2013 | 1.957B |
September 30, 2013 | 1.974B |
June 30, 2013 | 1.881B |
March 31, 2013 | 1.834B |
December 31, 2012 | 1.982B |
September 30, 2012 | 1.997B |
June 30, 2012 | 2.017B |
March 31, 2012 | 1.859B |
December 31, 2011 | 1.556B |
September 30, 2011 | 1.378B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
2.261B
Minimum
Mar 2023
5.144B
Maximum
Sep 2020
3.187B
Average
2.846B
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
DaVita Inc | 2.059B |
Biodexa Pharmaceuticals Plc | -8.984M |
NuCana PLC | -32.90M |
Biophytis SA | -13.97M |
TC BioPharm (Holdings) PLC | -13.16M |